3RIN
p38 kinase crystal structure in complex with small molecule inhibitor
Summary for 3RIN
| Entry DOI | 10.2210/pdb3rin/pdb |
| Descriptor | Mitogen-activated protein kinase 14, N-cyclopropyl-4-methyl-3-(2'-oxo-1',2'-dihydrospiro[cyclopentane-1,3'-indol]-6'-yl)benzamide (3 entities in total) |
| Functional Keywords | p38 map kinase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
| Biological source | Homo sapiens (human) |
| Cellular location | Cytoplasm (By similarity): Q16539 |
| Total number of polymer chains | 1 |
| Total formula weight | 41703.64 |
| Authors | Segarra, V.,Eastwood, P.,Roca, R.,Fisher, M.,Lamers, M. (deposition date: 2011-04-14, release date: 2012-02-29, Last modification date: 2023-09-13) |
| Primary citation | Eastwood, P.,Gonzalez, J.,Gomez, E.,Vidal, B.,Caturla, F.,Roca, R.,Balague, C.,Orellana, A.,Dominguez, M. Indolin-2-one p38(alpha) inhibitors I: design, profiling and crystallographic binding mode. Bioorg.Med.Chem.Lett., 21:4130-4133, 2011 Cited by PubMed Abstract: The use of structure-based design and molecular modeling led to the discovery of indolin-2-one derivatives as potent and selective p38α inhibitors. The predicted binding mode was confirmed by X-ray crystallography. PubMed: 21696951DOI: 10.1016/j.bmcl.2011.05.114 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.2 Å) |
Structure validation
Download full validation report






